Dec 15, 2023
January 26, 2025
This week’s newsletter included:
- Governor Cox Announces the Launch of the Utah Innovation Fund
- BioUtah Podcast Series: “Life Sciences in Action” with Meredith Krannich and Deno Himonas of Wilson Sonsini
- Halia Therapeutics Co-Founder David J. Bearss Featured in Utah Business
- Halia Therapeutics Dosed Its First Patient in Phase 2a Clinical Trial of HT-6184, a First-in-Class NLRP3-Inhibitor, for the Treatment of Lower-Risk Myelodysplastic Syndromes
- Central Texas Angel Network Makes Significant Investment in Phoenix PharmaLabs
- Inherent Biosciences Receives Investment from Utah Innovation Fund
- BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
- Two University of Utah Innovators Selected as National Academy of Inventors Fellows
- BioHive Wraps Up Food Drive
- Metrodora Hosts Governor Cox
- Technology Licensing Office at the University of Utah Announces New Processes for Tech Transfer
- 100 Companies Championing Women
Recent News
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
- Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
